INMED PHARMACEUTICALS INC. Inventory
INMED PHARMACEUTICALS INC. (INM) had Inventory of $947.90 thousand as of 2025-12-31, per its 10-Q filed 2026-02-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-07-02
- 2025-12-31: Inventory, Net $947.90K.
- 2025-09-30: Inventory, Net $890.81K.
- 2025-06-30: Inventory, Net $961.17K.
- 2025-03-31: Inventory, Net $813.97K.
| Period end | Inventory, Net |
|---|---|
| 2025-12-31 | $947.90K 10-Q · filed 2026-02-11 |
| 2025-09-30 | $890.81K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $961.17K S-4 · filed 2026-07-02 |
| 2025-03-31 | $813.97K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.10M 10-Q · filed 2025-02-12 |
| 2024-09-30 | $1.22M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.24M S-4 · filed 2026-07-02 |
| 2023-12-31 | $744.84K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $1.13M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.62M 10-K · filed 2024-09-30 |
| 2023-03-31 | $1.33M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.61M 10-Q · filed 2023-02-17 |
| 2022-09-30 | $1.78M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.49M 10-K · filed 2023-09-29 |
| 2022-03-31 | $1.42M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $988.82K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |